Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 6/2020

01-12-2020 | Hematology | Retraction Note

Retraction Note to: High-dose therapy and autologous stem cell transplantation for relapsed or high-risk diffuse large B-cell lymphoma: a nationwide survey

Authors: Sung-Won Kim, Yoshitaka Asakura, Kinuko Tajima, Toshiki Iwai, Hirofumi Taji, Takaaki Chou, Yasuo Morishima, Junji Suzumiya, Hisashi Sakamaki, Ritsuro Suzuki, Takahiro Fukuda

Published in: International Journal of Hematology | Issue 6/2020

Login to get access

Excerpt

The Editor-in-Chief has retracted the original article following an investigation by the National Cancer Center Hospital that concluded that the research took place before ethical approval was given. All authors agree to this retraction. …
Metadata
Title
Retraction Note to: High-dose therapy and autologous stem cell transplantation for relapsed or high-risk diffuse large B-cell lymphoma: a nationwide survey
Authors
Sung-Won Kim
Yoshitaka Asakura
Kinuko Tajima
Toshiki Iwai
Hirofumi Taji
Takaaki Chou
Yasuo Morishima
Junji Suzumiya
Hisashi Sakamaki
Ritsuro Suzuki
Takahiro Fukuda
Publication date
01-12-2020
Publisher
Springer Singapore
Published in
International Journal of Hematology / Issue 6/2020
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-020-03018-1

Other articles of this Issue 6/2020

International Journal of Hematology 6/2020 Go to the issue

Original Article

Evaluation of prognosis following early disease progression in peripheral T-cell lymphoma

Case Report

Allogeneic hematopoietic stem cell transplantation in a prior lung transplant recipient

Original Article

High-dose dexamethasone as a replacement for traditional prednisone as the first-line treatment in children with previously untreated primary immune thrombocytopenia: a prospective, randomized single-center study

Original Article

Treatment outcomes of IgG4-producing marginal zone B-cell lymphoma: a retrospective case series

Correction

Correction to: Programmed death 1 ligand (PD-L1) in solid cancers after allogeneic hematopoietic stem cell transplantation: a retrospective analysis by the Nagasaki Transplant Group

Case Report

Successful management of hemodialysis-dependent refractory myeloma with modified daratumumab, bortezomib and dexamethasone regimen
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits